financetom
Business
financetom
/
Business
/
Toyota Motor's US September Sales Drop; Electrified Vehicles Account For Nearly 50% Of Sales
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Toyota Motor's US September Sales Drop; Electrified Vehicles Account For Nearly 50% Of Sales
Oct 1, 2024 8:21 PM

Toyota Motor Corporation ( TM ) shares are trading slightly lower on Tuesday after the company reported U.S. September and third-quarter sales results.

Toyota Motor North America (TMNA) reported U.S. sales of 162,595 vehicles in September, a decline of 20.3% in volume and 9.9% on a daily selling rate basis.

“In September, nearly 50 percent of our total sales volume was an electrified model, an achievement made possible by our outstanding team and dealers,” said Jack Hollis, executive vice president, Sales, TMNA.

In September, electrified vehicle sales—including hybrids, plug-in hybrids, pure electrics, and fuel cells—accounted for 48.4% of total sales, totaling 78,683 units. This represents a 22.4% increase in volume and a 38.3% rise on a daily selling rate basis.

Also Read: General Motors Gives Q3 Delivery Update

Toyota ( TM ) division posted September sales of 140,152 vehicles, down 21.1% on a volume basis and down 10.8% on a DSR basis.

For the third quarter, the division sold 461,883 vehicles, down 10.4% on a volume basis and down 8.0% on a DSR basis. 

Lexus division posted September sales of 22,443 vehicles, down 14.5% on a volume basis and down 3.4% on a DSR basis. For the third quarter, the division sold 80,989 vehicles, up 8.1% on a volume basis and up 11.0% on a DSR basis.

“With 30 electrified vehicles now at Toyota ( TM ) and Lexus dealerships, Lexus sales recording its best-ever year-to-date result in its 35-year history, the all-new all-hybrid Toyota Camry a hit with customers, and Toyota ( TM ) remaining the number one retail brand in the industry, we are preparing to close out 2024 on a high note while continuing to focus on our customers,” Hollis added.

Price Action: TM shares are trading lower by 0.54% to $177.60 at last check Tuesday.

Read Next:

What’s Going On With NIO Stock Tuesday?

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Okta to Replace Berry Global on S&P MidCap 400
Okta to Replace Berry Global on S&P MidCap 400
May 25, 2025
04:24 AM EDT, 04/29/2025 (MT Newswires) -- Okta ( OKTA ) said Monday that it will replace Berry Global ( BERY ) on the S&P MidCap 400, effective Thursday. This comes as S&P 500 constituent Amcor (AMCR) is acquiring Berry in a deal expected to close soon, the company said. ...
Grupo Aeroportuario del Pacifico Q1 Income, Revenue Increase
Grupo Aeroportuario del Pacifico Q1 Income, Revenue Increase
May 25, 2025
04:23 AM EDT, 04/29/2025 (MT Newswires) -- Grupo Aeroportuario del Pacifico (PAC) reported Q1 comprehensive income Tuesday of 5.57 Mexican pesos per share ($0.28), up from about 4.28 pesos a year earlier. Comparable analyst estimates were not readily available. Revenue for the quarter ended March 31 was 11.06 billion pesos, up from 8.49 billion pesos a year earlier. Analysts surveyed...
Heron Therapeutics Names Mark Hensley as COO
Heron Therapeutics Names Mark Hensley as COO
May 25, 2025
04:21 AM EDT, 04/29/2025 (MT Newswires) -- Heron Therapeutics ( HRTX ) said late Monday that it appointed Mark Hensley as its chief operating officer. Before joining Heron, Hensley held several roles at Veloxis Pharmaceuticals, including chief executive officer from 2021 to 2024, and chief operating officer and chief commercial officer from 2018 to 2021. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved